ethinyl estradiol has been researched along with Atrial Septal Defect in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brockmeier, J; Carlsson, J; Meierhenrich, R; Miketic, S; Obergassel, L; Sorges, E; Tebbe, U | 1 |
| Schwetz, BA | 1 |
2 other study(ies) available for ethinyl estradiol and Atrial Septal Defect
| Article | Year |
|---|---|
[Pulmonary embolism with paradoxical coronary and peripheral arterial embolization. Increased risk of thrombosis caused by contraception with desogestrel and ethinylestradiol?].
Topics: Adult; Angiography; Contraceptives, Oral, Synthetic; Coronary Thrombosis; Desogestrel; Diagnosis, Differential; Echocardiography, Transesophageal; Ethinyl Estradiol; Female; Heart Septal Defects, Atrial; Humans; Pulmonary Embolism; Risk Factors; Thromboembolism; Thrombosis; Ulnar Artery | 1997 |
From the Food and Drug Administration.
Topics: Administration, Cutaneous; Adult; Child; Contraceptive Agents, Female; Dermatologic Agents; Ethinyl Estradiol; Female; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Humans; Isotretinoin; Levonorgestrel; Male; Prostheses and Implants; Risk Management; United States; United States Food and Drug Administration | 2002 |